Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statementFrancesco Locatelli, C. Wanner, Daniel Abramovicz et al.|Nephrology Dialysis Transplantation|2013Cited by 472
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruptionShazia Ashraf, Friedhelm Hildebrandt, Heon Yung Gee et al.|Journal of Clinical Investigation|2013Cited by 341
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluriaBernd Höppe, Dawn S. Milliner, Jaap W. Groothoff et al.|Nephrology Dialysis Transplantation|2011Cited by 144
Schimke immunoosseous dysplasia: suggestions of genetic diversityJ. Marietta Clewing, Sabine Sigaudy, Helen Fryssira et al.|Human Mutation|2006Cited by 64
Long-Term Transplantation Outcomes in Patients With Primary Hyperoxaluria Type 1 Included in the European Hyperoxaluria Consortium (OxalEurope) RegistryElisabeth L. Metry, Jaap W. Groothoff, Hessel Peters‐Sengers et al.|Kidney International Reports|2021Cited by 36